Jinsy Andrews, MD
Enriched profileProfessor of Neurology; Director, ALS Center; Medical Director, Clinical Trials · NYU Langone Health
Jinsy Andrews is Professor of Neurology; Director, ALS Center; Medical Director, Clinical Trials at NYU Langone Health. OpenAlex indexes 92 publications with 3,127 citations (h-index 28); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Sept 2026
Overview
Updated 18 Oct 2026
Jinsy Andrews, MD, is Professor of Neurology at NYU Langone Health / NYU Grossman School of Medicine, Department of Neurology. The public record shows 92 publications with 3,127 citations (h-index 28), centered on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Genetic Neurodegenerative Diseases. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 9 companies, 1 NIH-funded awards (2023–2026).
- Most recent indexed publication: 2025 · Clinical and translational science
- Top research focus: Amyotrophic Lateral Sclerosis Research
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 46.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Testified before the U.S. House Energy & Commerce Subcommittee on Health
July 29, 2021, hearing "The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases" …
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - Played a pivotal advocacy role in the passage of the ACT for ALS Act (H.R. 3537)
signed into law in December 2021, creating an FDA conditional-approval pathway and expanded-access/research funding for ALS
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Massachusetts General Hospital
Industry payments
Updated 18 Oct 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year20257 payments
- Regeneron Pharmaceuticals, Inc.Program year20254 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
76.9%Benzothiazole29.6%Riluzole100%Part D≥38 patientsOther nervous system drugs25.3%Radicava Ors100%Part D≥12 patients+ 5 more classes in this area
Metabolism & gastrointestinal
14%Anticholinergic10.3%Scopolamine68%Atropine Sulfate32%Part D<11 patientsCorticosteroid3.8%Prednisone100%Part D<11 patientsMusculoskeletal
6%gamma-Aminobutyric Acid-ergic Agonist6%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Access for All in ALS (ALL ALS) East Clinical Coordinating Center
Massachusetts General Hospital
FY2026$22,407,270OT2NS136938 - Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).
New York University School of Medicine
FY2026$10,658,357U01NS136023 - Access for All in ALS (ALL ALS) East Clinical Coordinating Center
Massachusetts General Hospital
FY2025$14,357,590OT2NS136938
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Modeling Investigation of the CYP1A Drug Interactions of Riluzole.
Clinical and translational science
Article2025 - COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Amyotrophic lateral sclerosis & frontotemporal degeneration
Clinical Trial2023 - MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
Amyotrophic lateral sclerosis & frontotemporal degeneration
Clinical Trial2023 - Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.
Journal of medical economics
Clinical Trial2023
Most-cited works
by citation count (OpenAlex)Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jinsy-andrews-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jinsy-andrews-md-msc-faan-fana-a83502ba
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
nyulangone.org/doctors/1710917232/jinsy-a-andrews
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Mentions by others
where others cite or feature them- Other
neals.org/about/leadership/jinsy-a-andrews-md-msc
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neals.org ↗ - Other
als.org/about-us/leadership/jinsy-andrews-md-msc-faan
- X / Twitter
x.com/alsassociation/status/1955732351948087687
- X / Twitter
x.com/nyulangone/status/1991871257797603525
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- MSc
Biostatistics, Mailman School of Public Health, Columbia University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - BA
Music and Biology, Union College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Editorial & leadership roles
journal and society appointments- Director
ALS Center, NYU Langone Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Medical Director
Clinical Trials, NYU Langone Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Professor
Department of Neurology, NYU Grossman School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Co-Principal Investigator
ALL ALS study (nationwide NIH-funded natural history and biomarker study)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- Fellow
American Academy of Neurology (FAAN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Fellow
American Neurological Association (FANA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Professor of Neurology
Columbia University Vagelos College of Physicians and Surgeons (past)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Director of Neuromuscular Clinical Trials
Columbia University Irving Medical Center (past)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - Senior Director of Clinical Research and Development
Cytokinetics Inc., South San Francisco (past, industry)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗ - Co-director
MDA/ALS Clinic, and Director of Research and Clinical Trials, Hospital for Special Care, New Britain, CT (past)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗ - Part-time Staff Physician
James J. Peters Veterans Affairs Medical Center (per Doximity profile)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Media & interviews
press, podcasts and appearances- Congressional testimony video: House Energy & Commerce Subcommittee on Health
"The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases"
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - NeuroVoices: Jinsy Andrews
MD, on Prodromal ALS, Emerging Biomarkers, and the Next Wave of Targeted Therapies (NeurologyLive video interview series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →als.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health